Abstract
Novel coronavirus disease 2019 (COVID-19) has posed a crucial hazard to global health. The new species share similarities with the two previously emerged entities: severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) that have caused outbreaks in 2002 and 2012, respectively. Interestingly, all of these coronaviruses can cause potentially fatal respiratory syndromes, though behave differently in patients with cancer compared to patients without cancer. Accordingly, the present chapter aims to, through a systematic investigation, estimate the prevalence of cancer among COVID-19, SARS, and MERS confirmed cases. Our analysis based on data from 78 studies with SARS, MERS, and COVID-19 confirmed cases showed that the prevalence of cancer (4.94%) stands at fourth place after hypertension (20.8%), diabetes (11.39%), and cardiovascular diseases (7.46%). According to the findings of the present study, comorbidities are significantly more common in patients with MERS compared to patients with COVID-19 and SARS, and this was the cancer case as well. Further studies need to address whether or not patients with coronaviruses and cancer are different from patients with coronaviruses without cancer in terms of clinical manifestations, laboratory findings, outcomes, and men to women ratio.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv
Ai J, Chen J, Wang Y, Liu X, Fan W, Qu G, Zhang M, et al. (2020) The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province. medRxiv
Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. Am J Roentgenol 203(4):782–787
Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, Memish ZA (2014) Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 59(2):160–165
Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B (2014) Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Int Med 160(6):389–397
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13(9):752–761
Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020a) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatrics Child Health. https://doi.org/10.1111/jpc.15048
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020b) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatrics Child Health
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Reviews Med Virol n/a (n/a):e2154. https://doi.org/10.1002/rmv.2154
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep:1–13. https://doi.org/10.1007/s12015-020-09994-5
Belmonte RL, Corbally M-K, Duneau DF, Regan JC (2020) Sexual Dimorphisms in Innate Immunity and Responses to Infection in Drosophila melanogaster. Front Immunol 10:3075
Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P (2003) Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289(21):2801–2809
Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z, Su Y, Ma Z, et al. (2020) COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. medRxiv
Cao B, Wang Y, Wen D, Liu W, Wang J, et al. (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787
Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S, Tsoi H-W, Lo SK-F, Chan K-H, Poon VK-M, Chan W-M, Ip JD, Cai J-P, Cheng VC-C, Chen H, Hui CK-M, Yuen K-Y (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395(10223):514–523. https://doi.org/10.1016/S0140-6736(20)30154-9
Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, et al. (2020a) Clinical progression of patients with COVID-19 in Shanghai, China. J Inf Secur
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y (2020b) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513
Chen X, Ling J, Mo P, Zhang Y, Jiang Q, Ma Z, Cao Q, et al. (2020c) Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. medRxiv
Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, et al. (2020d) Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. medRxiv
Chen X, Zheng F, Qing Y, Ding S, Yang D, Lei C, Yin Z, et al. (2020e) Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study. medRxiv
Cho SY, Kang JM, Ha YE, Park GE, Lee JY, Ko JH, Lee JY, Kim JM, Kang CI, Jo IJ, Ryu JG (2016, Sep 3) MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388(10048):994–1001
Cui P, Chen Z, Wang T, Dai J, Zhang J, Ding T, Jiang J, et al. (2020) Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China. medRxiv
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses
Desai A, Sachdeva S, Parekh T, Desai R (2020) COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 6:557–559. https://doi.org/10.1200/go.20.00097
Diao B, Feng Z, Wang C, Wang H, Liu L, Wang C, et al. (2020) Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv
Du R, Liang L, Yang C, Wang W, (2020a) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Am J Respir Crit Care Med
Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, … (2020b) Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med 201:1372
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44(9):1792–1797. https://doi.org/10.1002/cbin.11403
Gritti G, Raimondi F, Ripamonti D, Riva I, Landi F, … (2020) Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support. medRxiv
Guan W-j, Ni Z-y, Hu Y Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DS (2020a) Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv
Guan W, Liang W, Zhao Y, Liang H, … (2020b) Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, … (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA
Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.04.021
Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan-Yeung M, Tsang KW (2003) High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168(12):1449–1456. https://doi.org/10.1164/rccm.200306-766OC
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Huang Y, Zhou H, Yang R, Xu Y, Feng X, Gong P (2020b) Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv
Hui H, Zhang Y, Yang X, Wang X, He B, Li L, Li H, … (2020) Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. medRxiv
Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 here to stay? Disaster Medicine and Public Health Preparedness:1. https://doi.org/10.1017/dmp.2020.274
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep:1–2. https://doi.org/10.1017/dmp.2020.223
Jahanshahlu L, Rezaei N (2020a) Central Nervous System Involvement in COVID-19. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.016
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337. https://doi.org/10.1016/j.biopha.2020.110337
Jazieh AR, Alenazi TH, Alhejazi A, Al Safi F, Al Olayan A (2020) Outcome of oncology patients infected with coronavirus. JCO Glob Oncol
Jiang W, Zeng Z, Fan D, Zhang Y, Chen Z, … (2020) Decreased counts of T lymphocyte subsets predict prognosis in SARS-CoV-2-infected pneumonia in Wuhan, China: a retrospective study. … A Retrospective Study …
Kafieh R, Arian R, Saeedizadeh N, Minaee S, Yadav SK, Vaezi A, Rezaei N, Javanmard SH (2020) COVID-19 in Iran: a deeper look into the future. medRxiv
Kim KM, Ki M, Cho S-I, Sung M, Hong JK, Cheong H-K, Kim J-H, Lee S-E, Lee C, Lee K-J, Park Y-S, Kim SW, Choi BY (2015) Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital. Epidemiol Health 37:e2015041–e2015041. https://doi.org/10.4178/epih/e2015041
Kim E, Chin B, Kang C, Kim N, et al. (2020) … with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the korean cohort study on COVID-19. J Korean …. ncbi.nlm.nih.gov
Kui L, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, Xiao W, Wang Y-N, Zhong M-H, Li C-H (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J
Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, K.F. To, Lui SF, Szeto CC et al (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. https://doi.org/10.1056/NEJMoa030685
Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan L, et al. (2020) Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. Elsevier
Lescure F, Bouadma L, Nguyen D, Parisey M, et al. (2020) Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis
Li J, Zhang Y, Wang F, Liu B, Li H, Tang G, Chang Z, et al. (2020a) Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition. medRxiv
Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, Shen B, (2020b) Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China. medRxiv
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337
Liu L, Liu W, Wang S, Zheng S (2020a) A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients. medRxiv
Liu R, Ming X, Zhu H, Song L, Gao Z, Gao L, Jia S, et al. (2020b) Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: a hospital staff data. medRxiv
Lotfi M, Rezaei N (2020) SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. https://doi.org/10.1002/jmv.26123
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica chimica acta; Int J Clin Chem 508:254–266. https://doi.org/10.1016/j.cca.2020.05.044
Mackay IM, Arden KE (2015) MERS coronavirus: diagnostics, epidemiology and transmission. Virol J 12(1):222
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185
Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, Viswanathan M, Perez-Gutthann S (2014) Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa scale and the RTI item bank. Clinical Epidemiol 6:359
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N (2020a) Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infection control and hospital epidemiology:1-2. https://doi.org/10.1017/ice.2020.162
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of Covid-19: A systematic review. Available at SSRN 3583748
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 151(4):264–269
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N (2020) All together to Fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183. https://doi.org/10.4269/ajtmh.20-0281
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):205. https://doi.org/10.1186/s12967-020-02364-2
Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60–63
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-A tough opponent for the immune system. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.020
Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM (2014) Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14(11):1090–1095
Omrani-Nava V, Maleki I, Ahmadi A, Moosazadeh M (2020) Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients. Hepatitis Monthly. hepatmon.com
Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther:1–5. https://doi.org/10.1080/14712598.2020.1807933
Peiris JSM, Chu C-M, Cheng VC-C, Chan K, Hung I, Poon LL, Law K-I, Tang B, Hon T, Chan C (2003a) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361(9371):1767–1772
Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC, Chan KH, Tsang DNC, Yung RWH, Ng TK, Yuen KY, SARS study group (2003b) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. https://doi.org/10.1016/S0140-6736(03)13077-2
Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19. SN Comprehensive Clin Med:1–5
Prevention KCfDCa (2015) Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect. https://doi.org/10.1016/j.phrp.2015.08.006
Qi X, Jiang Z, Yu Q, Shao C, Zhang H, Yue H, Ma B, et al. (2020) Machine learning-based CT radiomics model for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study. medRxiv
Qin X, Qiu S, Yuan Y, Zong Y, Tuo Z, Li J, et al. (2020) Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China. China (February 18 …
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: Potential opportunities. Med Hypotheses 144:109917. https://doi.org/10.1016/j.mehy.2020.109917
Rezaei N (2020) COVID-19 and Medical Biotechnology. Avicenna J Med Biotechnol 12(3):139
Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother:1–3
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Rev Neurosci 31(4):453–456. https://doi.org/10.1515/revneuro-2020-0026
Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis.
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. (2020a) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20:425
Shi Q, Zhao K, Yu J, Feng J, Zhao K, Zhang X, Chen X, et al. (2020b) Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19: a single center, retrospective study. medRxiv
Shi Q, Zhao K, Yu J, Feng J, Zhao K, Zhang X, Chen X, Hu P, Hong Y, Li M (2020c) Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19: A single center, retrospective study. medRxiv
Shi Y, Yu X, Zhao H, Wang H, Zhao R, Cai Q, Sun S, Fang H, Wang Y, Hu Z (2020d) Host susceptibility to severe COVID-19: a retrospective analysis of a host risk score: findings of 487 cases outside Wuhan. Crit Care 24:108
Su H, Yang M, Wan C, Yi L, Tang F, Zhu H, Yi F, et al. (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International. Elsevier
Tan C, Zheng X, Huang Y, Liu J (2020) Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression. medRxiv
Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, Lam WK, Seto WH, Yam LY, Cheung TM, Wong PC, Lam B et al (2003) A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. https://doi.org/10.1056/NEJMoa030666
Tsui PT, Kwok ML, Yuen H, Lai ST (2003) Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 9(9):1064–1069. https://doi.org/10.3201/eid0909.030362
Wang Y-H, Lin A-S, Chao T-Y, Lu S-N, Liu J-W, Chen S-S, Lin M-C (2004a) A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med 30(6):1228–1231
Wang YH, Lin AS, Chao TY, Lu SN, Liu JW, Chen SS, Lin MC (2004b) A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med 30(6):1228–1231. https://doi.org/10.1007/s00134-004-2311-8
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020b) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585
Wang L, Gao Y, Zhang G (2020c) The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. Eur Respir J
Wang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J, et al. (2020d) Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect
Wang L, Li X, Chen H, Yan S, Li D, Li Y et al (2020e) Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol 51(5):343–348
Wang W, He J, Wu S (2020f) The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective …. medRxiv
Wang Z, Yang B, Li Q, Wen L, Zhang R (2020g) Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa272
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) Newcastle-Ottawa quality assessment scale cohort studies. Ontario: University of Ottawa
Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2016) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013.
WHO (2020) Coronavirus disease (COVID-19), Situation report – 142. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200610-covid-19-sitrep-142.pdf?sfvrsn=180898cd_2
Wu Z, McGoogan JM (2020a) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA
Wu Z, McGoogan JM (2020b) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242
Wu C, Chen X, Cai Y, Zhou X, Xu S, et al. (2020a) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180:934
Wu J, Liu J, Zhao X, Liu C, Wang W, et al. (2020b) Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis
Wu J, Liu J, Zhao X, Liu C, Wang W, et al. (2020c) Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis
Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. (2020a) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Med 47:1–6
Xu Y, Xu Z, Liu X, Cai L, Zheng H, Huang Y, Zhou L, et al. (2020b) Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study. medRxiv
Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, Dai J, et al. (2020a) Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect 80(4):388-393
Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, et al. (2020b) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir
Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900
Yazdanpanah F, Hamblin MR, Rezaei N (2020b) The immune system and COVID-19: friend or foe? Life Sci: 117900
Yazdanpanah N, Saghazadeh A, Rezaei N (2020c) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. https://doi.org/10.1515/revneuro-2020-0039
Yousefzadegan S, Rezaei N (2020) Case Report: Death due to COVID-19 in Three Brothers. Am J Trop Med Hyg 102(6):1203–1204
Zhang B, Zhou X, Qiu Y, Feng F, Feng J, Jia Y, Zhu H, et al. (2020a) Clinical characteristics of 82 death cases with COVID-19. medRxiv
Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, et al. (2020b) Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. medRxiv
Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. (2020c) Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan H, Peng L, Chen Y (2020d) Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China, Ann Oncol
Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, Jia M, Song Q, Fu Z (2020e) CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol. https://doi.org/10.1007/s00330-020-06854-1
Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S et al (2020f) Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. Int J Infect Dis 94:81–87
Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, Chen L, et al. (2020g) Comorbid diabetes mellitus was associated with poorer prognosis in patients with COVID-19: a retrospective cohort study. medRxiv
Zhao Z, Xie J, Yin M, Yang Y, He H, Jin T, Li W, Zhu X, et al. (2020) Clinical and laboratory profiles of 75 hospitalized patients with novel coronavirus disease 2019 in Hefei, China. medRxiv
Zhong N, Zheng B, Li Y, Poon L, Xie Z, Chan K, Li P, Tan S, Chang Q, Xie J (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362(9393):1353–1358
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet
房晓伟, 梅清, 杨田军, 张蕾, 杨云, 王胤中, 童飞, et al. (2020) 2019 新型冠状病毒感染的肺炎 79 例临床特征及治疗分析. html.rhhz.net
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fotouhi, M. et al. (2021). How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes?. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-63761-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63760-6
Online ISBN: 978-3-030-63761-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)